Literature DB >> 10410634

Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program.

G Atanackovic1, G Koren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10410634      PMCID： PMC1230407     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Motherisk--a new approach to antenatal counselling of drug/chemical exposure.

Authors:  G Koren; Y Feldman; N Shear
Journal:  Vet Hum Toxicol       Date:  1986-12

2.  Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate.

Authors:  A Pastuszak; G Koren; M J Rieder
Journal:  Reprod Toxicol       Date:  1994 Jan-Feb       Impact factor: 3.143

3.  Retinoic acid embryopathy.

Authors:  E J Lammer; D T Chen; R M Hoar; N D Agnish; P J Benke; J T Braun; C J Curry; P M Fernhoff; A W Grix; I T Lott
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

4.  A pregnancy-prevention program in women of childbearing age receiving isotretinoin.

Authors:  A A Mitchell; C M Van Bennekom; C Louik
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
  4 in total
  8 in total

1.  Oral isotretinoin: prescribers beware.

Authors:  N H Shear
Journal:  CMAJ       Date:  1999-06-15       Impact factor: 8.262

Review 2.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

Authors:  Laurent Azoulay; Driss Oraichi; Anick Bérard
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

4.  Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.

Authors:  Anick Bérard; Laurent Azoulay; Gideon Koren; Lucie Blais; Sylvie Perreault; Driss Oraichi
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

5.  Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.

Authors:  Nina Boucher; Louise Beaulac-Baillargeon
Journal:  Can Fam Physician       Date:  2006-03       Impact factor: 3.275

6.  Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.

Authors:  Margaret A Honein; Cynthia A Moore; J David Erickson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.

Authors:  David Henry; Colin Dormuth; Brandace Winquist; Greg Carney; Shawn Bugden; Gary Teare; Linda E Lévesque; Anick Bérard; J Michael Paterson; Robert W Platt
Journal:  CMAJ       Date:  2016-04-25       Impact factor: 8.262

8.  Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients.

Authors:  Angela E Ryan-Kewley; David R Williams; Neill Hepburn; Ronald A Dixon
Journal:  Front Microbiol       Date:  2017-07-25       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.